vs

Side-by-side financial comparison of Kennedy-Wilson Holdings, Inc. (KW) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $120.6M, roughly 1.6× Kennedy-Wilson Holdings, Inc.). Kennedy-Wilson Holdings, Inc. runs the higher net margin — 48.1% vs 6.7%, a 41.4% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs -11.0%). REPLIGEN CORP produced more free cash flow last quarter ($17.6M vs $-55.2M). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs -6.0%).

Kennedy Wilson is a real estate investment company headquartered in Beverly Hills, California, United States.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

KW vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.6× larger
RGEN
$197.9M
$120.6M
KW
Growing faster (revenue YoY)
RGEN
RGEN
+24.6% gap
RGEN
13.6%
-11.0%
KW
Higher net margin
KW
KW
41.4% more per $
KW
48.1%
6.7%
RGEN
More free cash flow
RGEN
RGEN
$72.8M more FCF
RGEN
$17.6M
$-55.2M
KW
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
-6.0%
KW

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
KW
KW
RGEN
RGEN
Revenue
$120.6M
$197.9M
Net Profit
$58.0M
$13.3M
Gross Margin
52.5%
Operating Margin
57.3%
9.0%
Net Margin
48.1%
6.7%
Revenue YoY
-11.0%
13.6%
Net Profit YoY
32.7%
143.9%
EPS (diluted)
$0.22
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KW
KW
RGEN
RGEN
Q4 25
$120.6M
$197.9M
Q3 25
$116.4M
$188.8M
Q2 25
$135.7M
$182.4M
Q1 25
$128.3M
$169.2M
Q4 24
$135.5M
$174.1M
Q3 24
$127.5M
$154.9M
Q2 24
$132.0M
$154.1M
Q1 24
$136.4M
$151.3M
Net Profit
KW
KW
RGEN
RGEN
Q4 25
$58.0M
$13.3M
Q3 25
$-10.2M
$14.9M
Q2 25
$5.6M
$14.9M
Q1 25
$-29.6M
$5.8M
Q4 24
$43.7M
$-30.3M
Q3 24
$-66.8M
$-654.0K
Q2 24
$-48.3M
$3.3M
Q1 24
$37.7M
$2.1M
Gross Margin
KW
KW
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
KW
KW
RGEN
RGEN
Q4 25
57.3%
9.0%
Q3 25
-6.2%
8.9%
Q2 25
7.4%
7.6%
Q1 25
-26.9%
3.9%
Q4 24
36.7%
-17.7%
Q3 24
-60.8%
-5.1%
Q2 24
-45.5%
1.0%
Q1 24
47.2%
1.3%
Net Margin
KW
KW
RGEN
RGEN
Q4 25
48.1%
6.7%
Q3 25
-8.8%
7.9%
Q2 25
4.1%
8.2%
Q1 25
-23.1%
3.4%
Q4 24
32.3%
-17.4%
Q3 24
-52.4%
-0.4%
Q2 24
-36.6%
2.2%
Q1 24
27.6%
1.4%
EPS (diluted)
KW
KW
RGEN
RGEN
Q4 25
$0.22
$0.24
Q3 25
$-0.15
$0.26
Q2 25
$-0.05
$0.26
Q1 25
$-0.30
$0.10
Q4 24
$0.24
$-0.55
Q3 24
$-0.56
$-0.01
Q2 24
$-0.43
$0.06
Q1 24
$0.19
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KW
KW
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$184.5M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$1.5B
$2.1B
Total Assets
$6.6B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KW
KW
RGEN
RGEN
Q4 25
$184.5M
$767.6M
Q3 25
$382.6M
$748.7M
Q2 25
$309.1M
$708.9M
Q1 25
$356.6M
$697.2M
Q4 24
$217.5M
$757.4M
Q3 24
$367.1M
$784.0M
Q2 24
$366.5M
$809.1M
Q1 24
$541.9M
$780.6M
Total Debt
KW
KW
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
KW
KW
RGEN
RGEN
Q4 25
$1.5B
$2.1B
Q3 25
$1.5B
$2.1B
Q2 25
$1.6B
$2.1B
Q1 25
$1.6B
$2.0B
Q4 24
$1.6B
$2.0B
Q3 24
$1.6B
$2.0B
Q2 24
$1.7B
$2.0B
Q1 24
$1.7B
$2.0B
Total Assets
KW
KW
RGEN
RGEN
Q4 25
$6.6B
$2.9B
Q3 25
$6.7B
$2.9B
Q2 25
$6.8B
$2.9B
Q1 25
$7.2B
$2.9B
Q4 24
$7.0B
$2.8B
Q3 24
$7.4B
$2.8B
Q2 24
$7.5B
$2.9B
Q1 24
$7.7B
$2.8B
Debt / Equity
KW
KW
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KW
KW
RGEN
RGEN
Operating Cash FlowLast quarter
$11.4M
$25.7M
Free Cash FlowOCF − Capex
$-55.2M
$17.6M
FCF MarginFCF / Revenue
-45.8%
8.9%
Capex IntensityCapex / Revenue
55.2%
4.1%
Cash ConversionOCF / Net Profit
0.20×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$-103.5M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KW
KW
RGEN
RGEN
Q4 25
$11.4M
$25.7M
Q3 25
$-7.6M
$48.1M
Q2 25
$42.0M
$28.6M
Q1 25
$-51.9M
$15.0M
Q4 24
$55.1M
$39.2M
Q3 24
$-5.6M
$49.3M
Q2 24
$36.7M
$42.2M
Q1 24
$-5.6M
$44.7M
Free Cash Flow
KW
KW
RGEN
RGEN
Q4 25
$-55.2M
$17.6M
Q3 25
$-18.0M
$43.4M
Q2 25
$29.4M
$21.5M
Q1 25
$-59.7M
$11.4M
Q4 24
$-76.5M
$33.6M
Q3 24
$-27.7M
$42.3M
Q2 24
$-500.0K
$37.4M
Q1 24
$-57.1M
$36.4M
FCF Margin
KW
KW
RGEN
RGEN
Q4 25
-45.8%
8.9%
Q3 25
-15.5%
23.0%
Q2 25
21.7%
11.8%
Q1 25
-46.5%
6.8%
Q4 24
-56.5%
19.3%
Q3 24
-21.7%
27.3%
Q2 24
-0.4%
24.3%
Q1 24
-41.9%
24.0%
Capex Intensity
KW
KW
RGEN
RGEN
Q4 25
55.2%
4.1%
Q3 25
8.9%
2.5%
Q2 25
9.3%
3.9%
Q1 25
6.1%
2.1%
Q4 24
97.1%
3.2%
Q3 24
17.3%
4.5%
Q2 24
28.2%
3.1%
Q1 24
37.8%
5.5%
Cash Conversion
KW
KW
RGEN
RGEN
Q4 25
0.20×
1.93×
Q3 25
3.23×
Q2 25
7.50×
1.92×
Q1 25
2.57×
Q4 24
1.26×
Q3 24
Q2 24
12.70×
Q1 24
-0.15×
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KW
KW

Consolidated Portfolio Segment$84.9M70%
Investment Management Fees$30.4M25%
Real Estate$5.1M4%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons